Cambridge Nutritional Science (CNSL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.65p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.35
  • 52 Week Low: 1.73
  • Currency: UK Pounds
  • Shares Issued: 237.95m
  • Volume: 455,064
  • Market Cap: £8.69m

Omega's professional-use Covid test rejected by UK regulator

By Josh White

Date: Friday 11 Mar 2022

LONDON (ShareCast) - (Sharecast News) - Omega Diagnostics announced another disappointment for its Covid-19 tests on Friday, announcing that the UK Health Security Agency said its application for approval of the professional-use 'VISITECT' antigen test under the Coronavirus Test Device Approvals regulations (CTDA) was unsuccessful.
The AIM-traded firm said as a result, the product would not be available for sale in the general UK market.

It said some supporting data provided by third-party development partners, submitted for the desktop review, used comparator 'RT-qPCR', or quantitative reverse transcription PCR, results from studies conducted in late 2020 and early 2021, which pre-date the CTDA regulations.

Some of these comparator tests were not CE-marked, or did not meet the sensitivity and specificity requirements of the CTDA.

Those results thus had to be excluded from the review and, as a result, there were insufficient test results to meet the CTDA requirements.

Currently, with insufficient demand for the professional-use test, the company said it did not plan to commission further studies.

Its board said it believed the self-test market was "much more relevant" in terms of opportunity, as the company worked with its external study centres to ensure the 31 March deadline was met for the submission of the outstanding self-test CE-mark data.

"Whilst this is clearly disappointing, our plans do not include any contribution from Covid-19 antigen tests, as we focus the business on driving growth in our health and nutrition division," said chief executive officer Jag Grewal.

At 1537 GMT, shares in Omega Diagnostics were up 1.93% at 4.23p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CNSL Market Data

Currency UK Pounds
Share Price 3.65p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.35
52 Week Low 1.73
Volume 455,064
Shares Issued 237.95m
Market Cap £8.69m

CNSL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
73.17% above the market average73.17% above the market average73.17% above the market average73.17% above the market average73.17% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income Not Available
Growth Not Available

CNSL Dividends

No dividends found

Trades for 15-Jul-2024

Time Volume / Share Price
13:05 50,052 @ 3.51p
12:16 18,000 @ 3.51p
09:54 200,000 @ 3.57p
10:23 15,532 @ 3.51p
09:54 100,000 @ 3.56p

Top of Page